Surveillance and outbreak reports Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S

First Page		Document Content
Date: 2014-06-10 04:24:00 Microbiology HIV test Viral load Hepatitis C virus AIDS Hepatitis C HIV Coinfection Antiretroviral drug HIV/AIDS Health Medicine		Surveillance and outbreak reports Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S Add to Reading List Source URL: www.hepatitis-c-initiative.eu Download Document from Source Website File Size: 218,14 KB Share Document on Facebook

	Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study DocID: 1vngt - View Document
	PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno DocID: 1vlwz - View Document
	PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes    DocID: 1vjI2 - View Document
	Contact PD/PI: Braithwaite, Ronald Scott A. SPECIFIC AIMS Many persons with HIV have Hepatitis C (HCV) co-infection and consume alcohol.1,2 Now that highly effective and easily tolerated therapies for HCV are available, DocID: 1vbzY - View Document
	PRESS RELEASE AbbVie’s TECHNIVIE™ Receives Health Canada Approval for Genotype 4 Chronic Hepatitis C Infection  TECHNIVIE provides an opportunity to treat adults who have genotype 4 (GT4) chronic hepatitis C DocID: 1vais - View Document